* Reports H1 net loss of 2.0 million zlotys ($531,420.22) versus loss of 1.8 million zlotys year on year
* H1 net loss 5.2 million euros ($5.8 million) versus loss of 10.8 million euros a year ago
* Capital increase in Onxeo resulting from the exercise of share subscription options from employees
* Reports H1 total net loss of 13.0 million euros ($14.6 million), as compared to a loss of 7.2 million euros a year ago
No related earnings announcements are currently scheduled within the next 7 days.